In subjects with moderate to severe hepatic impairment, a 30% reduction in clearance of lanreotide was observed.
Evidence role
Reported: reviewed reported observation that should not be pooled as a comparable value yet
Assay / model
human
Condition
Lanreotide · 6e4a41fd-a753-4362-87ee-8cc56ed3660d · 12.3 Pharmacokinetics · lanreotide hepatic impairment clearance reduction text · In subjects with moderate to severe hepatic im...
